<![CDATA[A U.S. jury found Japan-based Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza via an anticompetitive scheme.]]>A U.S. jury found Japan-based Takeda Pharmaceutical liable for causing about $885 million in damages by delaying a generic version of its constipation drug Amitiza via an anticompetitive scheme. https://www.japantimes.co.jp/business/2026/05/19/companies/takeda-antitrust-generic-constipation-drug/?utm_medium=Social&utm_source=mastodon

]]>https://postcall.pub/topic/827aedad-214b-4fbb-a5a3-174ad8495ca0/a-u.s.-jury-found-japan-based-takeda-pharmaceutical-liable-for-causing-about-885-million-in-damages-by-delaying-a-generic-version-of-its-constipation-drug-amitiza-via-an-anticompetitive-scheme.RSS for NodeMon, 25 May 2026 01:30:19 GMTTue, 19 May 2026 09:30:09 GMT60